After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the I (Q72560583)
Jump to navigation
Jump to search
scientific article published on 01 November 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the I |
scientific article published on 01 November 1993 |
Statements
After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study (English)
G I Barbash
M Modan
J Simes
R Diaz
J R Hampton
J Heikkilä
A Kristinsson
S Moulopoulos
1 November 1993